Anthony Tardi’s Post

Join the EDUCARE Platform to Explore Advanced Vascular Intervention Strategies! During LINC 2024, a compelling symposium provided expert insights into enhancing patient outcomes in endovascular interventions. Here’s a summary of what you may have missed: •Critical Factors for Success: Understanding the impact of dissection patterns and minimal stent area on reintervention rates and long-termpatency. •Vessel Preparation and StentOptimization: Emphasizing the importance of adequate vessel prep, particularly in long occlusions and calcifiedlesions, to preventrestenosis. •Cost-Effectiveness of DES: How the use of ELUVIA™ DES can significantly reduce reintervention costs and improve overall treatment efficiency. Elevate your clinical practice by catching up on thisinsightful session. 👉 Access the Full Session on EDUCARE:  https://lnkd.in/daSUmMqv

Register now for a live webinar on November 12th at 1pm-2pm EST with Carmin Bartow! Learn about Above Cuff Vocalization (ACV) for patients with tracheostomy and mechanical ventilation. Patients with tracheostomy and mechanical ventilation often struggle with communication. Above Cuff Vocalization (ACV) allows patients to speak audibly even with an inflated cuff, reducing anxiety and enhancing quality of life. This course will outline the steps for using ACV and highlight the importance of a multidisciplinary team for successful clinical implementation. It will also review evidence on the benefits and potential complications of ACV. Earn 0.1 ASHA CEUs. Link in comments to register.

This is a brilliant idea.....using an IO to start an IV. But it comes with lots of questions. ⇨ Why would this be necessary? ⇨ Is this for EMS or for Hospitals? ⇨ If I already have an IO, why do I need an IV? Join us tomorrow at 11AM EST on the NAEMSP Florida Chapter Webinar to hear directly from the authors of a recent publication that describes this procedure, called GAHP. What is GAHP.. Graduated Access for Hypotensive Patients: First place the IO… then FILL the vessels in that extremity. It works well for peripheral OR central lines.. with or without ultrasound.

TREAT-NMD is thrilled to announce our participation at the upcoming Muscular Dystrophy Association Clinical & Scientific Conference in Orlando from March 3-6, 2024 - one of the most exciting events in the NMD calendar! David Allison, Clare Bradley and Kelly Evans will be there on behalf of TREAT-NMD and they would love to chat so please stop them to say hello! As well as attending we are once again proud to be partnering with the Muscular Dystrophy Association (MDA) and the FSHD Society to deliver a CE accredited session for delegates as part of the Clinical Considerations track at the event. The session will be chaired by Jeffrey M. Statland (University of Kansas Medical Center, USA), accompanied by expert clinicians, who will focus on providing 'An Overview of Therapeutics for FSHD'. This collaboration underscores our commitment to advancing knowledge and fostering collaboration within the neuromuscular community. We’d love for you to join (either in person or virtually) to explore the latest advancements, breakthroughs, and clinical considerations in the field of neuromuscular disorders. Together with MDA, we aim to create a platform for insightful discussions and networking opportunities. For more information about the event and to register to attend go to > https://lnkd.in/g9NtQfY #NMDs #NeuromuscularDiseases #NeuromuscularResearch #MDAConference #CollaborationInScience #FSHDeducation #FSHD

Predictive Medicine - Moving from Reaction to Proactive Care What if you could predict a patient's health trajectory and intervene before disease strikes? 🤔 Predictive medicine is turning this vision into reality. 💫 Our upcoming conference "Novel technologies for clinical application in 3P medicine" will feature expert discussions on the latest advancements in predictive diagnostics, prevention and personalisation strategies.  Discover the tools and technologies that can help you anticipate patient needs before symptoms even arise. 👉 Join us in Tivat, Montenegro, 11-12th of October to network with pioneers in 3P medicine and bring these innovations back to your practice

#FamilialHypercholesterolemia a frequent monogenic disorder causing premature ASCVD. An underdiagnosed and undertreated disorder. What's new in the management of patients with FH that can reduce CV risk ? come to #ISCP2024 in Sao Paulo and discuss about this topic. Thanks to International Society of Cardiovascular Pharmacotherapy for this opportunity

Thankful for the opportunity to present with Tufts Medical Center at ICCAI 2024. With significant adverse outcomes of interventions like TAVR (10% to 20% mortality at 1 year), enhanced long term risk stratification might be useful, especially in managing elderly & frail populations, optimizing outcomes and reducing waste. The conference is hosted by the Society for Complex Acute Illness. The word “complex” here is key to our narrative, as acute illness involves multiorgan dysregulation that can be seen in loss of signal complexity at multiple time scales associated with the breakdown of nonlinear regulatory feedback loops. Our results show that selected beat scales may optimize measurement of the change in information content embedded in BP waveforms (via entropy metrics) showing different cardiac contractile function and vascular systemic elastance, which variables may directly affect outcomes. Special Thanks to Ebenezer Tolman, Ethan Brovman, Sage Tuchsen, Emery Amtmann and Timothy Ruchti

Το τελευταίο μας άρθρο: Check out our latest paper on IGF1 levels and high cortisol: you can't use IGF1 for clinical decisions in Cushing's patients! Weinberg, J.R et al. The utility of IGF1 in the evaluation of pediatric patients with endogenous hypercortisolemia. Pediatr Res (2023).https://lnkd.in/d6kFDbPz https://rdcu.be/drZmh

Save the date! 3-4 April in Lisbon, or online; The 1st International Conference on Clinical and Scientific Advances in ME/CFS and Long COVID aims to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion among healthcare professionals, investigators, policymakers, patients, and community representatives on the clinical manifestations, management, therapeutic options, and health challenges related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID. https://lnkd.in/d7pJWtzY

🌞 Registered!!! Some of the topics I’m excited to listen from top experts in the field 🌊 🏄♂️ 🏝️ Mayo Clinic Mechanical Ventilation Conference 2024 Oceanside, CA US October 16, 2024 to October 19, 2024 Cardiopulmonary Interactions – Principles for Lung AND Heart Protective Mechanical Ventilation John J. Marini, M.D. When To Use and When Not to Use the Word ‘ARDS’ Jean-Louis Vincent, M.D., Ph.D. Mechanical Ventilation and Lung Transplantation: From Ex Vivo Lung Perfusion (EVLP) To Perioperative Ventilatory Management Jorge M. Mallea, M.D. How Do I Assess Lung Recruitment and Tritrate PEEP? Laurent J. Brochard, M.D. Interactive Session “Catch the Wave” Waveform Analysis and Patient-Ventilator Dyssynchrony William M. LeTourneau, II, R.R.T., L.R.T.; James E. Baker, R.R.T., L.R.T.; Tanner J. Hill, R.R.T., L.R.T.